Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01974232 · ClinicalTrials.gov registry record

A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

A clinical trial, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
33
Enrollment target

NCT01974232 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 33 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01974232 has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
33 participants
Enrollment target

Study Summary

This is a retrospective analysis of children (≤21years old) who received clinical treatment with either Romiplostim or Eltrombopag at 2 medical centers from 2009-2013. The children included in this study were from Weill Medical College of Cornell University, New York, New York and Children's Hospital Orange County, Orange, California

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2012-01
Est. Completion 2013-06

What the Registry Record Tells You About NCT01974232

The ClinicalTrials.gov registry entry for NCT01974232 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01974232 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01974232 about?

NCT01974232 is a clinical study titled "A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013". This is a retrospective analysis of children (≤21years old) who received clinical treatment with either Romiplostim or Eltrombopag at 2 medical centers from 2009-2013. The children included in this study were from Weill Medical College of Cornell University, New York, New York and Children's Hospita...

What is the current status of trial NCT01974232?

This trial is currently completed. The enrollment target is 33 participants. The study started on 2012-01. Estimated completion is 2013-06.

Who is sponsoring clinical trial NCT01974232?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.